# Prophylactic Antibiotics After Cesarean

> **NCT03187106** · PHASE1 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 321 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Cephalexin
- **DRUG:** Placebo
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT03187106
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-07-21
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187106, "Prophylactic Antibiotics After Cesarean". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03187106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*